NeuroPace, Inc. NPCE released preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for drug-resistant idiopathic generalized epilepsy (IGE).The study met its primary 12-week post-implant safety endpoint, demonstrating a low rate of serious adverse events related to the device and implant procedure.The study did not reach statistical significance for the primary effectiveness endpoint in the overall study population, which was to s ...

UnitedHealth Group Inc. UNH is officially in the technical doghouse. The healthcare titan just plunged to its most oversold level on both the weekly and monthly charts since the 2008 financial crisis, according to Barchart. The stock has cratered 42% year-to-date, and a staggering 30% in just the past month—leaving even the most hardened bulls shell-shocked.Read Also: As UnitedHealth Wipes Out ‘Unthinkable’ $140 Billion In Market Value Since April, Analysts Weigh In On The Road AheadUNH Stock Breaks Down Te ...

Meeting with Intercontinental Exchange Inc's ICE top management indicated that the company is poised for durable earnings growth of more than 10%, "with healthy momentum” across its three business segments, according to Goldman Sachs.The Intercontinental Exchange Analyst: Analyst Alexander Blostein maintained a Buy rating.The Intercontinental Exchange Thesis: The company is poised to benefit from structural shifts in the energy segment and improving growth in mortgage, Blostein said in the note.Check out ot ...

Semtech Corporation SMTC will release its first-quarter earnings results after the closing bell on Tuesday, May 27.Analysts expect the Camarillo, California-based company to report quarterly earnings at 37 cents per share, up from 6 cents per share in the year-ago period. Semtech projects to report quarterly revenue at $250.09 million, compared to $206.1 million a year earlier, according to data from Benzinga Pro.On May 12, Semtech announced that Mitch Haws has joined the company as its senior vice presiden ...

U.S. stocks traded higher this morning, with the Nasdaq Composite surging more than 300 points on Tuesday. President Donald Trump announced the extension of the 50% tariffs on Sunday till July 9, which he had initially announced on Friday.Following the market opening Tuesday, the Dow traded up 0.95% to 41,997.56 while the NASDAQ surged 1.78% to 19,070.48. The S&P 500 also rose, gaining, 1.33% to 5,879.93.Check This Out: Jim Cramer Says Rocket Is A ‘Very Fine’ Company, Recommends Buying This Health Care Stoc ...

公司当前周期阶段 - Blackstone目前处于其18阶段Adhishthana周期的第6阶段 当前阶段有利于价值积累 但真正的突破潜力可能要到2026年底才会完全显现 [1] - 公司已完成一个完整的18阶段周期 当前周期始于2021年10月11日 其股价表现与Adhishthana原则的契合度高达99% [2] 历史阶段表现 - 第1阶段(Śokā)实现+98.58%回报 第2阶段(Buddhi)下跌52% 第3阶段(Yajña)上涨73.64% 第5阶段(Tyaga)下跌42% [3] - 第5阶段通常会出现回踩前阶段低点的走势 称为"放弃水平" 该回踩已在周线图表完成 强化了当前估值吸引力 [6] 关键价格水平分析 - 月线图表显示公司处于第5阶段 预计不会回踩前阶段59.81美元低点 因第5阶段开盘价较第4阶段中点104.80美元高出9% [11] - 104美元是关键支撑位 与周线第3阶段中点重合 形成高概率测试区域 若股价触及该水平后企稳 将重启价值买盘 [12] - 假设第6阶段高点为152美元 回踩104美元后 预计"涅槃水平"将落在129-130美元区间 若2025年10月20日前股价低于该水平 将形成长期价值买点 [13] 未来关键时间节点 - 2026年3月30日公司将进入周线第9阶段 该阶段通常出现持续突破行情 称为"喜马拉雅式攀升" [14] - 2025年10月19日需确认第6阶段涅槃水平 若股价保持在该水平下方 将为2026年的突破行情奠定基础 [7][15] 投资机会评估 - 当前价位适合长期投资者开始布局 但全面上行潜力需等待2026年下半年显现 [16] - 短期可能回调至104美元 这属于健康修正 待该水平测试完成且涅槃水平确认后 将形成结构性突破条件 [15]

Elon Musk has promised robotaxis every year since 2016 – and now, the latest vow is that Tesla Inc TSLA will launch a fleet in Austin, Texas, by June. But while Tesla talks a big game, it is Alphabet Inc's GOOGL GOOG Waymo and Baidu Inc's BIDU Apollo Go that are clocking miles and making money (or at least, showing a clear path to it).Waymo's Mileage Speaks Louder Than Musk's WordsAlphabet’s Waymo recently crossed a massive milestone: 10 million paid robotaxi rides—double what it achieved five months ago.Wi ...

Macy’s, Inc. M will release its first-quarter financial results before the opening bell on Wednesday, May 28.Analysts expect the company to report quarterly earnings at 14 cents per share, down from 27 cents per share in the year-ago period and quarterly revenue of $4.5 billion, compared to $4.85 billion a year earlier, according to data from Benzinga Pro.On May 6, Morgan Stanley analyst Alex Straton maintained Macy’s with an Equal-Weight rating and lowered the price target from $14 to $12.With the recent b ...

公司动态 - Ross Stores Inc (ROST) 在5月23日上午10:09出现Power Inflow信号 交易价格为13050美元 该信号被活跃交易者视为看涨指标 可能预示股价上行趋势 [3][4] - Power Inflow信号通常出现在市场开盘后两小时内 反映机构资金动向 对当日剩余交易时段的股价方向有指引作用 [6] - 信号触发后 ROST股价最高达13777美元 收盘报13746美元 较信号触发价分别上涨56%和53% [8] 交易信号分析 - Power Inflow属于订单流分析范畴 通过分解零售与机构订单流量 分析买卖订单规模 时间等特征 辅助交易决策 [5] - 该信号表明机构资金("聪明钱")正在流入 交易者可将其作为潜在入场点 捕捉预期上涨行情 [4] - 订单流分析能帮助市场参与者更准确解读市场状况 识别交易机会 但需结合风险管理策略 [7] 数据服务 - Benzinga Pro提供ROST期权交易的实时警报服务 数据来源包括TradePulse等合作机构 [8]

Prothena Corporation plc PRTA released data from the Phase 3 AFFIRM-AL clinical trial evaluating birtamimab in patients with AL amyloidosis on Friday.AL (amyloid light-chain) amyloidosis is a systemic disease where abnormal proteins, called amyloid fibrils, accumulate in various organs. It’s the most common type of systemic amyloidosis.The Phase 3 AFFIRM-AL trial enrolled 207 newly diagnosed patients. Birtamimab was given to the active arm every 28 days at a dose level of 24 mg/kg (maximum dose not to excee ...